Arrowhead Pharmaceuticals Depreciation & Amortization 2011-2026 | ARWR

Annual Depreciation & Amortization Arrowhead Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
22.2 M	16.9 M	10.7 M	8.7 M	6.6 M	4.2 M	2.7 M	3 M	2.99 M	3.26 M	2.34 M	1.35 M	1.75 M	1.75 M	268 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
22.2 M	268 K	5.91 M

Quarterly Depreciation & Amortization Arrowhead Pharmaceuticals

2025-Q2	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
5.8 M	4.8 M	-	4.4 M	4.1 M	3.8 M	-	2.9 M	2.2 M	2.3 M	-	2.2 M	2.2 M	2.1 M	-	1.6 M	1.5 M	1.4 M	2.9 M	1.1 M	1.4 M	800 K	2.08 M	578 K	835 K	752 K	3.47 M	2.29 M	1.18 M	1.14 M	3.54 M	1.16 M	1.14 M	1.19 M	2.42 M	818 K	1.19 M	794 K	1.48 M	741 K	794 K	290 K	1.08 M	276 K	396 K	403 K	1.35 M	454 K	9.56 M	450 K	1.3 M	423 K	450 K	454 K	5.66 M	66.5 K	454 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
9.56 M	66.5 K	1.85 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Aptorum Group Limited APM	1.13 M	$ 1.06	-0.93 %	$ 5.78 M	China
Autolus Therapeutics plc AUTL	7.55 M	$ 1.82	-4.85 %	$ 464 M	Britain
Adagene ADAG	723 K	$ 1.65	-	$ 92.9 M	China
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Biogen BIIB	673 M	$ 187.4	0.75 %	$ 27.3 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
BioXcel Therapeutics BTAI	309 K	$ 1.98	-1.0 %	$ 5.02 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
CASI Pharmaceuticals CASI	468 K	$ 1.04	-2.34 %	$ 142 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Catalyst Biosciences CBIO	1.07 M	$ 10.74	-2.1 %	$ 707 M	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Celldex Therapeutics CLDX	3.18 M	$ 27.0	-1.28 %	$ 1.74 M	USA
BioVie BIVI	229 K	$ 1.27	-2.31 %	$ 1.88 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	9.45 M	-	-15.15 %	$ 60.3 M	Britain
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Amphastar Pharmaceuticals AMPH	28.2 M	$ 27.75	0.02 %	$ 1.34 B	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 4.14	-3.72 %	$ 9.01 B	Israel
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Biohaven Pharmaceutical Holding Company Ltd. BHVN	24.9 M	$ 11.13	-2.02 %	$ 720 M	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Axon Enterprise AXON	48.4 M	$ 633.45	3.34 %	$ 48 B	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	5.38 M	$ 2.64	-0.75 %	$ 16.6 M	USA
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	11 K	-	-9.72 %	$ 5.89 M	USA